Meta-analysis supports association of a functional SNP (rs1801133) in the MTHFR gene with Parkinson's disease.

作者: Zhi-gang Zhu , Qing-long Ai , Wen-min Wang , Zhi-cheng Xiao

DOI: 10.1016/J.GENE.2013.07.034

关键词:

摘要: Abstract The MTHFR is a candidate risk gene for Parkinson's disease (PD), and functional SNP (rs1801133) in the coding region of this has been investigated associations with illness extensively among worldwide populations, but overall results were inconsistent. Here, to assess relationship between rs1801133 PD general we conducted systematic meta-analysis by combining all available case–control samples European Asian total 1820 cases 7530 healthy controls, pooled odds ratios (ORs) 95% confidence intervals (95% CIs) calculated using Mantel–Haenszel method fixed-effect model. Overall, was significantly associated (allelic model, OR = 1.212 T allele, CI = 1.097–1.340, p-value = 0.0002). When stratifying ethnicity, significant association also observed OR = 1.187 CI = 1.058–1.332, p-value = 0.004) OR = 1.293 CI = 1.058–1.580, p-value = 0.012) respectively. In addition, mRNA expression both CEU (European, p-value = 0.0149) CHB (Chinese, p-value = 0.0178) HapMap populations. Collectively, our suggests that susceptibility likely an authentic PD.

参考文章(34)
J. T. Greenamyre, BIOMEDICINE: Parkinson's--Divergent Causes, Convergent Mechanisms Science. ,vol. 304, pp. 1120- 1122 ,(2004) , 10.1126/SCIENCE.1098966
Colin B. Begg, Madhuchhanda Mazumdar, Operating characteristics of a rank correlation test for publication bias. Biometrics. ,vol. 50, pp. 1088- 1101 ,(1994) , 10.2307/2533446
D L Harmon, D Ramsbottom, A S Whitehead, Y Ben-Shlomo, G Davey-Smith, The thermolabile variant of 5,10-methylenetetrahydrofolate reductase is not associated with Parkinson's disease. Journal of Neurology, Neurosurgery, and Psychiatry. ,vol. 62, pp. 671- 671 ,(1997) , 10.1136/JNNP.62.6.671
William D. Dupont, Walton D. Plummer, Power and sample size calculations. A review and computer program. Controlled Clinical Trials. ,vol. 11, pp. 116- 128 ,(1990) , 10.1016/0197-2456(90)90005-M
Ullrich Wüllner, Heike Kölsch, Michael Linnebank, Methylenetetrahydrofolate reductase in Parkinson's disease. Annals of Neurology. ,vol. 58, pp. 972- 973 ,(2005) , 10.1002/ANA.20696
Gaetano Gorgone, Monica Currò, Nadia Ferlazzo, Giulia Parisi, Lucilla Parnetti, Vincenzo Belcastro, Nicola Tambasco, Aroldo Rossi, Francesco Pisani, Paolo Calabresi, Riccardo Ientile, Daniela Caccamo, Coenzyme Q10, Hyperhomocysteinemia and MTHFR C677T Polymorphism in Levodopa-treated Parkinson’s Disease Patients NeuroMolecular Medicine. ,vol. 14, pp. 84- 90 ,(2012) , 10.1007/S12017-012-8174-1
Jolanta Dorszewska, Wojciech Kozubski, Joanna Jaroszewska-Kolecka, Wieslaw H. Trzeciak, Bartosz Kempisty, Agata Rozycka, Jolanta Florczak, Katarzyna Chojnacka, Oxidative DNA damage and level of thiols as related to polymorphisms of MTHFR, MTR, MTHFD1 in Alzheimer's and Parkinson's diseases. Acta Neurobiologiae Experimentalis. ,vol. 67, pp. 113- 129 ,(2007)
D. Religa, K. Czyzewski, M. Styczynska, B. Peplonska, J. Lokk, M. Chodakowska-Zebrowska, K. Stepien, B. Winblad, M. Barcikowska, Hyperhomocysteinemia and methylenetetrahydrofolate reductase polymorphism in patients with Parkinson's disease. Neuroscience Letters. ,vol. 404, pp. 56- 60 ,(2006) , 10.1016/J.NEULET.2006.05.040
D. Caccamo, G. Gorgone, M. Currò, G. Parisi, W. Di Iorio, C. Menichetti, V. Belcastro, L. Parnetti, A. Rossi, F. Pisani, R. Ientile, P. Calabresi, Effect of MTHFR polymorphisms on hyperhomocysteinemia in levodopa-treated Parkinsonian patients. Neuromolecular Medicine. ,vol. 9, pp. 249- 254 ,(2007) , 10.1007/S12017-007-8006-X